Medicinske upotrebe

Farmakologija

Hemija

Osobine

Reference

1. ^^абIndex Nominum 2000: International Drug Directory. Taylor & Francis. јануар 2000. стр. 44—.ISBN 978-3-88763-075-1. CS1 одржавање: Формат датума (веза)
2. ^^абвSmith MB (23. 10. 2013).„Biologically Important Amino Acids”.Methods of Non-α-Amino Acid Synthesis (Second изд.). CRC Press. стр. 146—.ISBN 978-1-4665-7789-3. CS1 одржавање: Формат датума (веза)
3. ^Cooper JR, Bloom FE, Roth RH (2003).The Biochemical Basis of Neuropharmacology. Oxford University Press. стр. 112—.ISBN 978-0-19-514007-1. 
4. ^Melis GB, Paoletti AM, Mais V, Mastrapasqua NM, Strigini F, Fruzzetti F, et al. (2014). „Dose-related effects of gamma-amino beta-hydroxy butyric acid (GABOB) infusion on growth hormone secretion in normal women”.Journal of Endocrinological Investigation.5 (2): 101—106.PMID 7096918.S2CID 71239193.doi:10.1007/BF03350499. 
5. ^^абHayashi T (март 1959).„The inhibitory action of beta-hydroxy-gamma-aminobutyric acid upon the seizure following stimulation of the motor cortex of the dog”.The Journal of Physiology.145 (3): 570—578.PMC 1356963 .PMID 13642322.doi:10.1113/jphysiol.1959.sp006163. CS1 одржавање: Формат датума (веза)
6. ^^абвгCorelli F, Mugnaini C (17. 1. 2017).„Chemistry of GABA_B Receptor Ligands: Focus on Agonists and Antagonists”. Ур.: Colombo G.GABAB Receptor. Springer. стр. 25—.ISBN 978-3-319-46044-4. CS1 одржавање: Формат датума (веза)
7. ^Roberts E, Krause DN, Wong E, Mori A (фебруар 1981).„Different Efficacies of d- and l-γ-Amino-β-Hydroxybutyric Acids in GABA Receptor and Transport Test Systems”.The Journal of Neuroscience.1 (2): 132—140.PMC 6564147 .PMID 6267220.doi:10.1523/JNEUROSCI.01-02-00132.1981. CS1 одржавање: Формат датума (веза)
8. ^Demaio D, Pasquariello G (октобар 1963). „Gamma-amino-beta-hydroxybutyric acid (GABOB) and brain serotonin”.Psychopharmacologia.5 (1): 84—86.PMID 14085623.S2CID 1436623.doi:10.1007/BF00405577. CS1 одржавање: Формат датума (веза)
9. ^Chemello R, Giaretta D, Pellegrini A, Testa G (1980). „[Effect of gamma-amino-beta-hydroxybutyric acid (GABHB) on experimentally-induced epileptic activity]” [Effect of γ-amino-β-hydroxybutyric acid (GABHB) on experimentally-induced epileptic activity].Rivista di Neurologia (на језику: италијански).50 (4): 253—268.PMID 7466221. 
10. ^García-Flores E, Farías R (1997). „gamma-Amino-beta-hydroxybutyric acid as add-on therapy in adult patients with severe focal epilepsy”.Stereotactic and Functional Neurosurgery.69 (1-4 Pt 2): 243—246.PMID 9711762.doi:10.1159/000099882. 
11. ^Lapin I (2001).„Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug”.CNS Drug Reviews.7 (4): 471—481.PMC 6494145 .PMID 11830761.doi:10.1111/j.1527-3458.2001.tb00211.x. 
12. ^Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”.The Journal of Physical Chemistry A.102 (21): 3762—3772.Bibcode:1998JPCA..102.3762G.doi:10.1021/jp980230o. 
13. ^Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”.Journal of Chemical Information and Computer Sciences.41 (6): 1488—1493.PMID 11749573.doi:10.1021/ci000392t. 
14. ^Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”.Journal of Medicinal Chemistry.43 (20): 3714—3717.PMID 11020286.doi:10.1021/jm000942e. 

Literatura

• Hardman JG, Limbird LE, Gilman AG (2001).Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill.ISBN 0071354697.doi:10.1036/0071422803. 
• Thomas L. Lemke; David A. Williams, ур. (2007).Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins.ISBN 0781768799. 

Spoljašnje veze